Target- |
MechanismCholesterol absorption inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Germany |
First Approval Date20 Jun 1999 |
100 Clinical Results associated with HOYER GmbH
0 Patents (Medical) associated with HOYER GmbH
100 Deals associated with HOYER GmbH
100 Translational Medicine associated with HOYER GmbH